Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02131194Completed
Randomised, double-blind trial (2 arms), sponsored by Lenstatin. Primary endpoint: Pentacam Nuclear Density Measurements at 6 months. Started Jun 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02131194.